BACKGROUND: Stress fractures commonly affect military recruits during basic training. Several lines of evidence suggest genetic factors are involved in stress fracture predisposition. As gender steroid hormone levels and activity have been implicated in affecting bone strength, one of the candidate genes likely to be involved is the androgen receptor gene. QUESTIONS/PURPOSES: We assessed the possible involvement of the androgen receptor gene in stress fracture predisposition in Israeli soldiers. PATIENTS AND METHODS: Between January 2007 and December 2009, we collected clinical and imaging data from 454 Israeli soldiers referred for bone scans with clinical symptoms compatible with stress fractures: 171 soldiers (154 men, 17 women) (patients) with bone scan-proven stress fractures and 283 soldiers (242 men, 41 women) with normal bone scans (control subjects). All participants were genotyped for the length of the CAG (cytosine-adenine-guanine) repeat in exon 1 of the androgen receptor gene using PCR and subsequent fragment analysis on sequence analyzer. RESULTS: The androgen receptor gene CAG repeat was ranged between six and 31 (mean ± SD, 20.6 ± 4.3) among patients and between 11 and 32 (mean ± SD, 20.0 ± 3.8) among control subjects. Smaller-sized (< 16) androgen receptor CAG repeats were more prevalent among control subjects (23%) than among patients (13%); the risk for having SFs was almost halved if the size of the repeat was shorter than 16 repeats. CONCLUSIONS: The androgen receptor gene CAG repeat has a different allele distribution among Israeli soldiers with stress fractures than in control subjects. While our finding must be validated, it could be used for screening individuals at risk for stress fractures. LEVEL OF EVIDENCE: Level II, prognostic study. See the Guidelines for Authors complete description of levels of evidence.
BACKGROUND:Stress fractures commonly affect military recruits during basic training. Several lines of evidence suggest genetic factors are involved in stress fracture predisposition. As gender steroid hormone levels and activity have been implicated in affecting bone strength, one of the candidate genes likely to be involved is the androgen receptor gene. QUESTIONS/PURPOSES: We assessed the possible involvement of the androgen receptor gene in stress fracture predisposition in Israeli soldiers. PATIENTS AND METHODS: Between January 2007 and December 2009, we collected clinical and imaging data from 454 Israeli soldiers referred for bone scans with clinical symptoms compatible with stress fractures: 171 soldiers (154 men, 17 women) (patients) with bone scan-proven stress fractures and 283 soldiers (242 men, 41 women) with normal bone scans (control subjects). All participants were genotyped for the length of the CAG (cytosine-adenine-guanine) repeat in exon 1 of the androgen receptor gene using PCR and subsequent fragment analysis on sequence analyzer. RESULTS: The androgen receptor gene CAG repeat was ranged between six and 31 (mean ± SD, 20.6 ± 4.3) among patients and between 11 and 32 (mean ± SD, 20.0 ± 3.8) among control subjects. Smaller-sized (< 16) androgen receptorCAG repeats were more prevalent among control subjects (23%) than among patients (13%); the risk for having SFs was almost halved if the size of the repeat was shorter than 16 repeats. CONCLUSIONS: The androgen receptor gene CAG repeat has a different allele distribution among Israeli soldiers with stress fractures than in control subjects. While our finding must be validated, it could be used for screening individuals at risk for stress fractures. LEVEL OF EVIDENCE: Level II, prognostic study. See the Guidelines for Authors complete description of levels of evidence.
Authors: T Remes; S B Väisänen; A Mahonen; J Huuskonen; H Kröger; J S Jurvelin; I M Penttilä; R Rauramaa Journal: Bone Date: 2003-04 Impact factor: 4.398
Authors: L Westberg; F Baghaei; R Rosmond; M Hellstrand; M Landén; M Jansson; G Holm; P Björntorp; E Eriksson Journal: J Clin Endocrinol Metab Date: 2001-06 Impact factor: 5.958
Authors: Amelia Guadalupe-Grau; Francisco Germán Rodríguez-González; Jesús Gustavo Ponce-González; Cecilia Dorado; Hugo Olmedillas; Teresa Fuentes; Jorge Pérez-Gómez; Joaquín Sanchís-Moysi; Bonifacio Nicolás Díaz-Chico; José A L Calbet Journal: PLoS One Date: 2010-07-12 Impact factor: 3.240
Authors: Marcia C Willing; James C Torner; Trudy L Burns; Kathleen F Janz; Teresa Marshall; Julie Gilmore; Sachi P Deschenes; John J Warren; Steven M Levy Journal: Osteoporos Int Date: 2003-07-22 Impact factor: 4.507
Authors: Ian Varley; Julie P Greeves; Craig Sale; Eitan Friedman; Daniel S Moran; Ran Yanovich; Peter J Wilson; Alison Gartland; David C Hughes; Trent Stellingwerff; Craig Ranson; William D Fraser; James A Gallagher Journal: Purinergic Signal Date: 2016-01-29 Impact factor: 3.765